Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

UBIMOTIF

Financiado

Cerrado

Short linear interaction motifs as specificity determinants in the ubiquitin sys...

Short linear interaction motifs as specificity determinants in the ubiquitin system discovery mechanisms and therapeutic opportunities A major challenge is the lack of therapeutic approaches for numerous human diseases, which poses a societal challenge. The ubiquitin system is a major promising source for novel therapeutic approaches but its potential has not bee... ver más

31/05/2024

UCPH

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

KOBENHAVNS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 11 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2024-05-31

MSCA-ITN-2019: Innovative Training Networks

I+D

Cerrada hace 6 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

11 Participantes

UCPH

808.27K€ | Lider

ETH Zürich

281.28K€ | Participante

THE HEBREW UNIVERSITY OF JER...

263.50K€ | Participante

ICR

303.17K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

UPSTREAM European Research Training in the Ubiquitin Proteasome Syste... 3M€ Cerrado

UBIQUITON Development of a tool kit to investigate protein ubiquitylat... 150K€ Cerrado

Ubl-tool Development of a chemical biology toolbox for deciphering th... 2M€ Cerrado

TARGET-PPIS Targeting the ubiquitin proteasome system and ubiquitin like... 100K€ Cerrado

BFU2011-28536 IDENTIFICACION DE PERFILES DE UBICUITILACION ASSOCIADOS A PR... 138K€ Cerrado

TRIM-NET Training network in drug discovery targeting TRIM Ubiquitin... 3M€ Cerrado

Duración del proyecto: 57 meses Fecha Inicio: 2019-08-09
Fecha Fin: 2024-05-31

Líder del proyecto

KOBENHAVNS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto A major challenge is the lack of therapeutic approaches for numerous human diseases, which poses a societal challenge. The ubiquitin system is a major promising source for novel therapeutic approaches but its potential has not been fully exploited due to limited insight and lack of researchers trained in understanding and identifying avenues to target the ubiquitin system. Ubiquitin ligases and deubiquitinating enzymes (DUBs) comprises enzymes that actively add or remove ubiquitin from proteins to regulate cell physiology. How these enzymes selectively recognize their substrates is largely unknown but an emerging theme is that a globular domain in the enzyme binds a short linear interaction motif (SLiM) in the substrate. SLiMs are short peptide motifs that constitute ideal entry points for understanding the ubiquitin system as they provide detailed insight into substrate selection and how this regulates the underlying biology. Further, SLiMs provide direct routes to therapeutic exploitation as they serve as peptide scaffolds for drug development and tools to highjack the ubiquitin system. The potential of SLiMs has not been capitalized upon because a method for efficient identification was missing, interactions between relevant partners were lacking and this has hampered training of young researchers. UBIMOTIF overcomes these barriers by exploiting novel technological advances to identify SLiMs and uniting outstanding complementary researchers and industrial partners with a common vision to provide outstanding training of early career scientist in SLiMs and the ubiquitin system. The UBIMOTIF topic provides ideal training of young researchers, as it requires a multidisciplinary and intersectorial approach providing training in multiple cutting-edge technologies. The impact of UBIMOTIF will be unprecedented insight into the ubiquitin system, novel therapeutic opportunities and a skilled workforce that can fill the exhausted pipelines of European companies.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores